Back pain, particularly in the lower back, is one of the most prevalent health issues worldwide, affecting millions of people each year. Despite a wide array of available treatments, a recent scientific review highlights how difficult it remains to find consistently effective relief. The findings shed light on both the promise and the limitations of common therapies, offering a clearer picture of what truly works—and for whom.
Key Highlights:
- Effective for Acute Pain: The review found that nonsteroidal anti-inflammatory drugs (NSAIDs)—such as aspirin, ibuprofen, and naproxen—are the only treatments that consistently provide relief for acute low back pain, which typically lasts less than six weeks.
- Limited Success for Chronic Pain: For chronic back pain, which persists for more than three months, five interventions—including exercise—were identified as somewhat helpful. However, the benefits were only slightly better than those of a placebo, highlighting the challenge of managing long-term pain.
- Individualized Responses Matter: Even when the average benefits of a treatment appear small or negligible, some individuals may experience significant relief, depending on their unique biological makeup, lifestyle, and other personal factors. This underscores the importance of personalized care and the need for continued research into tailored treatment strategies.
As researchers continue to explore new options, this review reinforces the need for realistic expectations and a personalized approach to back pain management.
The Study
Lower back pain is a nearly universal human experience, with studies estimating that up to 80% of people will experience it at some point in their lives. If you’re among them, chances are you’ve tried at least one noninvasive or nonsurgical treatment—maybe even several. But if those methods haven’t brought you lasting relief, you’re far from alone. A new comprehensive scientific review has found that many commonly used therapies offer little to no benefit, and even the most effective ones typically only produce modest improvements.
The study, recently published in BMJ Evidence-Based Medicine, analyzed the results of 301 clinical trials and assessed the effectiveness of 56 different treatments or treatment combinations for both acute (short-term) and chronic (long-term) low back pain. What researchers discovered paints a sobering picture: only about one in ten treatments for acute back pain provided reliable relief, while just five therapies for chronic pain outperformed placebos—though only slightly.
“It was surprising to see that so few treatments were effective, and that when effective, the benefits were mostly modest,” said Aidan Cashin, PhD, the study’s lead author and deputy director of the Center for Pain Impact at Neuroscience Research Australia.
Acute vs. Chronic Pain: Key Differences and Definitions
The study defined acute low back pain as discomfort lasting less than 12 weeks, while chronic pain was characterized by symptoms persisting beyond that period. A total of 52 of the reviewed trials involved patients with acute pain, 228 focused on chronic pain, and 21 included individuals with both types.
Dr. Cashin emphasized that the complexity of low back pain makes it inherently difficult to treat. “Low back pain is a common and complex problem which can be difficult to treat due to many possible contributors that could be causing and maintaining an individual’s back pain experience,” he said. “More work is needed to better understand what causes and maintains low back pain so we can develop more targeted treatments.”
NSAIDs Work for Acute Pain — But That’s About It
Among the treatments for acute low back pain, only nonsteroidal anti-inflammatory drugs (NSAIDs)—including familiar options like aspirin, ibuprofen, and naproxen—stood out as consistently effective. These medications were shown to reduce pain intensity better than placebos, based on standardized scales evaluating patient-reported pain levels.
Common treatments such as acetaminophen (Tylenol), steroid injections, and exercise, however, were found to be ineffective in relieving acute back pain symptoms. For other widely used therapies like acupuncture, massage, spinal manipulation, heat application, and TENS (transcutaneous electrical nerve stimulation), the evidence was inconclusive due to poor study design, small sample sizes, or low-quality data.
In terms of pharmacological interventions, the study found limited or uncertain results for cannabinoids, immunoglobulins, opioids, ozone injections, and muscle relaxants, underscoring the need for more rigorous research.
For Chronic Pain, Five Treatments Show Modest Benefits
When it comes to chronic low back pain, the picture becomes even murkier. Only five treatments showed consistent, albeit modest, effectiveness:
- Exercise
- Spinal manipulation
- Lower back taping
- Antidepressants
- Topical warming creams
Although these therapies performed better than placebos, the improvements were generally small. “Our review did not find reliable evidence of large effects for any of the included treatments,” the authors wrote, reinforcing the notion that chronic back pain may require more nuanced, multimodal strategies rather than relying on a single solution.
Treatments that were shown to have no benefit for chronic pain included antibiotics and anesthetics like lidocaine. Many others—including massage, acupuncture, TENS, osteopathy, and combinations of antidepressants and acetaminophen—had inconclusive evidence of efficacy.
The Limitations of Averages: One Size Doesn’t Fit All
Despite these broad findings, experts caution against assuming that these results mean nothing will work for most patients. Sean Mackey, MD, chief of the division of pain medicine at Stanford Health Care, noted that one of the key takeaways from the study is the need for individualized treatment plans.
“What is notable is the relative scarcity of high-quality, larger-scale placebo-controlled research for certain commonly used treatments,” Mackey said. “This highlights an ongoing need for more rigorous and collaborative research in this area.”
Dr. Mackey, who was not involved in the review, also warned about misinterpreting the data. “My greatest concern is that people will see this as a sign that 90% of treatments don’t work. But that’s not accurate. For most treatments, the evidence was inconclusive, rather than definitively negative.”
“These findings don’t imply that nothing works,” he added. “A treatment showing small or no average benefit may still significantly help specific patients based on their unique pain mechanisms, preferences, and biology. This is why personalized medicine approaches are essential in pain management.”
The Case for Multidisciplinary, Personalized Care
Experts agree that a one-size-fits-all approach doesn’t apply to back pain. According to Dr. Mackey, the best path forward is often a multidisciplinary one that combines physical therapy, psychological support, lifestyle changes, and medication as needed.
“There is no single ‘magic bullet’ treatment for back pain, and modest expectations for any single intervention are appropriate,” he said. “If one therapy doesn’t work, you may need to explore others or a combination. Listen to professional advice and track what improves your quality of life, not just pain scores.”
This approach aligns with a growing emphasis in medicine on tailoring treatments to the individual. With back pain, that might mean balancing exercise with cognitive behavioral therapy, using medication as a short-term support rather than a long-term solution, and remaining open to alternative therapies that may not yet have strong clinical backing but work well for a particular person.
Future Research: A Crucial Next Step
The study authors and external experts alike agree that there is a pressing need for better research. Many of the trials reviewed were limited by low-quality design, lack of placebo controls, or insufficient sample sizes. As a result, firm conclusions could not be drawn for many of the interventions.
“While we would like to provide more certain recommendations for where to invest and disinvest in treatments, it is not possible at this time,” the study authors wrote.
They hope their findings will help guide future clinical trials and funding priorities, encouraging more rigorous and expansive studies that can clarify which treatments hold real promise—and for whom.
Hope, Despite the Challenges
While the results may seem discouraging, they offer a critical reminder: back pain is complex, and what works for one person may not work for another. But with a thoughtful, evidence-based approach and a willingness to adapt over time, it is possible to find meaningful relief.
As science continues to dig deeper into the mechanisms behind back pain, more precise and effective treatments will likely emerge. Until then, understanding the limits of current therapies can empower patients and providers to make better-informed decisions—and keep searching for what works best on an individual level.
Recommended For You
